Increased demand for medical gases drove up Carbacid’s six months revenue to Kes 449.7 million, a 27% improvement from the Kes352.9 million revenue earned in the same period in 2019.
The company’s net profit jumped 18% to Kes 210.4 million in the half-year period that ended on January 31 2021 from Kes178.7 million in the corresponding period in 2019.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
